Abstract
Stroke is the third leading cause of death and the leading cause of disability in contemporary society. Aneurysmal subarachnoid hemorrhage (aSAH) is a hemorrhagic stroke which accounts for 7% of all stroke cases and 22 to 25% of cerebrovascular deaths. Aneurysmal subarachnoid hemorrhage is a very complex disease and many controversies on its pathophysiology and management have not yet been settled. The aim of this review is to present the most recent evidence-based advances in the pathophysiology and perioperative management of aSAH.
Keywords: Subarachnoid hemorrhage, vasospasm, stroke, delayed neurologic deficits.
Current Pharmaceutical Design
Title:Perioperative Management of Intracranial Aneurysm and Subarachnoid Hemorrhage
Volume: 19 Issue: 32
Author(s): Ehab Farag, Zeyd Ebrahim, David Traul, Irene Katzan and Edward Manno
Affiliation:
Keywords: Subarachnoid hemorrhage, vasospasm, stroke, delayed neurologic deficits.
Abstract: Stroke is the third leading cause of death and the leading cause of disability in contemporary society. Aneurysmal subarachnoid hemorrhage (aSAH) is a hemorrhagic stroke which accounts for 7% of all stroke cases and 22 to 25% of cerebrovascular deaths. Aneurysmal subarachnoid hemorrhage is a very complex disease and many controversies on its pathophysiology and management have not yet been settled. The aim of this review is to present the most recent evidence-based advances in the pathophysiology and perioperative management of aSAH.
Export Options
About this article
Cite this article as:
Farag Ehab, Ebrahim Zeyd, Traul David, Katzan Irene and Manno Edward, Perioperative Management of Intracranial Aneurysm and Subarachnoid Hemorrhage, Current Pharmaceutical Design 2013; 19 (32) . https://dx.doi.org/10.2174/13816128113199990062
DOI https://dx.doi.org/10.2174/13816128113199990062 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Strategies for the Preparation of Bifunctional Gadolinium(III) Chelators
Current Organic Synthesis Role of microRNAs on Blood Brain Barrier Dysfunction in Vascular Cognitive Impairment
Current Drug Delivery Inflammatory Events Following Subarachnoid Hemorrhage (SAH)
Current Neuropharmacology Recent Advances in Pathophysiology of Traumatic Brain Injury
Current Neuropharmacology Intracranial Non-traumatic Aneurysms in Children and Adolescents
Current Pediatric Reviews Matrix Metalloproteinases as Valid Clinical Target
Current Pharmaceutical Design Genetic Variability of Matrix Metalloproteinase Genes in Cardiovascular Disease
Current Topics in Medicinal Chemistry Currently Used Biologic Agents in the Management of Behcet’s Syndrome
Current Medicinal Chemistry Perspectives of Gene Therapies in Autosomal Dominant Polycystic Kidney Disease
Current Gene Therapy Amino Acid Metabolic Routes in Trypanosoma cruzi: Possible Therapeutic Targets Against Chagas; Disease
Current Drug Targets - Infectious Disorders Pharmacoproteomics in Cardiac Hypertrophy and Atherosclerosis
Cardiovascular & Hematological Disorders-Drug Targets Monocytes, Macrophages and Other Inflammatory Mediators of Abdominal Aortic Aneurysm
Current Pharmaceutical Design Randomized Clinical Stroke Trials in 2006
Current Vascular Pharmacology Proteomics and Cardiovascular Disease: An Update
Current Medicinal Chemistry Chemistry and Theranostic Applications of Radiolabeled Nanoparticles for Cardiovascular, Oncological, and Pulmonary Research
Current Topics in Medicinal Chemistry Histone Methylation and Transcriptional Regulation in Cardiovascular Disease
Cardiovascular & Hematological Disorders-Drug Targets New Mechanisms and Targets of Subarachnoid Hemorrhage: A Focus on Mitochondria
Current Neuropharmacology All for Statins and Statins for All; An Update
Current Pharmaceutical Design Matrix Metalloproteinases: Drug Targets for Myocardial Infarction
Current Drug Targets Importance of Receptor-targeted Systems in the Battle Against Atherosclerosis
Current Pharmaceutical Design